A61P 1 - Drugs for disorders of the alimentary tract or the digestive system

Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
10/2006
10/24/2006	US7125559 Cosmetic or dermatological composition comprising a combination of an elastase inhibitor of the N-acylaminoamide family and at least one myorelaxing agent
10/24/2006	US7125555 Oral preparation containing seaweed for reduction of plaque and calculus
10/24/2006	CA2273549C Diagnostic agents for pancreatic exocrine function
10/24/2006	CA2264598C 1,2,3,4-tetrahydro-benzofuro[3,2-c]pyridine derivatives
10/24/2006	CA2227711C Thioctic acid metabolites and methods of use thereof
10/24/2006	CA2195663C Dihydrobenzofuranes
10/19/2006	WO2006110406A2 Compositions comprising probiotic and sweetener components
10/19/2006	WO2006110088A1 Selection and use of lactic acid bacteria for reducing inflammation in mammals
10/19/2006	WO2006109881A1 Combined use of prostaglandin compound and proton pump inhibitor for the treatment of gastrointestinal disorders
10/19/2006	WO2006109867A1 PYRAZOLO[1,5-a]PYRIDINE DERIVATIVE OR MEDICALLY ACCEPTABLE SALT THEREOF
10/19/2006	WO2006109855A1 Peptide having food intake stimulating effect and method for screening for the peptide
10/19/2006	WO2006109846A1 Triazole derivative and the use thereof
10/19/2006	WO2006109817A1 1,4-substituted piperazine derivative
10/19/2006	WO2006109762A1 Novel process for producing ramosetron or its salt
10/19/2006	WO2006109633A1 Substituted indole compound
10/19/2006	WO2006109344A2 Composition to be used for the treatment of parodontal pathologies
10/19/2006	WO2006109058A1 New bicyclic angiotensin ii agonists
10/19/2006	WO2006109056A1 New tricyclic angiotensin ii agonists
10/19/2006	WO2006109048A1 New tricyclic angiotensin ii agonists
10/19/2006	WO2006108689A2 Process for preparing bicyclic compounds
10/19/2006	WO2006108208A1 A method for the treatment of gastrointestinal and other disorders with an admixture of vitamins and minerals
10/19/2006	WO2003027637A3 Assessment of neurons in the arcuate nucleus to screen for agents that modify feeding behavior
10/19/2006	US20060235054 e.g. 3-substituted 5-(4-fluorophenyl)-4-(4-pyridyl)imidazole-2-thione; immunomodulating and cytokine-release-inhibiting action; antiinflammatory agent
10/19/2006	US20060235053 Agents for the treatment of lower abdominal disorders
10/19/2006	US20060235026 Quinoline-4-Carboxamide Derivatives as NK-3 and NK-2 Receptor Antagonists
10/19/2006	US20060235023 Inhibitors of macrophage migration inhibitory factor and methods for indentifying the same
10/19/2006	US20060235011 N-cyclopropylmethyl-N-7-[2,6-dimethoxy-4-(methoxymethyl)phenyl]-2-ethylpyrazolo[1,5-a]pyridin-3-yl-N-tetrahydro-2H-4-pyranylmethylamine; depressive symptom, mania, anxiety, general anxiety disorder, panic disorder, phobia, obsessive-compulsive disorder, posttraumatic stress disorder, Tourette's syndrome
10/19/2006	US20060234991 Combinations for the treatment of immunoinflammatory disorders
10/19/2006	US20060234964 nucleatide sequences that code transforming growth factor beta (TGF- beta), for the treatment of autoimmune diseases such as inflammatory bowel disease
10/19/2006	US20060234955 Cardiac glycosides to treat cystic fibrosis and other il-8 dependent disorders
10/19/2006	US20060234924 A kit for screening a compound or its salt that promotes or inhibits the activity of the proteins; drug screening for hyperlipemia, arteriosclerosis, genital, digestive, respiratory diseases, renal, pancreatic, central nerve, respiratory, inflammatory, rheumatoid diseases and diabetic neurosis
10/19/2006	US20060234905 Method of stimulating growth and resistance to diseases of aquatic organisms
10/19/2006	US20060233877 Betaine compositions
10/19/2006	US20060233796 Method of modulating memory effector T-cells and compositions
10/19/2006	US20060233746 N-terminally chemically modified protein compositions and methods
10/19/2006	US20060233724 Medicinal composition for peridontal pocket administration containing bisphosphonic acid derivative or its salt as the active ingredient
10/19/2006	US20060233709 Method for identifying novel treatments of inflammatory disease in the gut
10/19/2006	DE19720437B4 Mutanase enthaltende orale Zusammensetzungen Mutanase containing oral compositions
10/19/2006	DE102005061720B3 Preparing optically active omeprazole enantiomers, useful to treat stomach diseases, comprises oxidizing prochiral sulfide compound with oxidizing agent in presence of titanium complex catalyst and reacting the catalyst with chiral diols
10/19/2006	CA2605377A1 Ghrelin binding nucleic acids
10/19/2006	CA2604835A1 Compositions comprising probiotic and sweetener components
10/19/2006	CA2604822A1 Novel process for producing ramosetron or its salt
10/19/2006	CA2604797A1 New tricyclic angiotensin ii agonists
10/19/2006	CA2604397A1 Process for preparing bicyclic compounds
10/19/2006	CA2604038A1 New tricyclic angiotensin ii agonists
10/19/2006	CA2603701A1 1,4-substituted piperazine derivative
10/19/2006	CA2603457A1 Pyrazolo[1,5-a]pyridine derivatives or pharmaceutically acceptable salts thereof
10/19/2006	CA2603254A1 New bicyclic angiotensin ii agonists
10/19/2006	CA2602812A1 Combined use of prostaglandin compound and proton pump inhibitor for the treatment of gastrointestinal disorders
10/19/2006	CA2583972A1 A method for the treatment of gastrointestinal and other disorders with an admixture of vitamins and minerals
10/19/2006	CA2544038A1 Pharmaceutical compositions for the treatment of ulcerations
10/18/2006	EP1712555A1 Prodrug comprising 5-aminosalicylate glycoside
10/18/2006	EP1712239A2 Interleukin-1 inhibitors in the treatment of diseases
10/18/2006	EP1712230A1 Pharmaceutical composition for xerophthalmia and xerostomia treatment
10/18/2006	EP1712225A1 Substituted carbostyril derivatives as 5-HT 1A receptor subtype agonists
10/18/2006	EP1711597A2 Human hepatic progenitor cells and methods of use thereof
10/18/2006	EP1711179A2 Calcium, potassium, zinc, lithium and aluminium salts of pantoprazole and (s)-pantoprazole
10/18/2006	EP1711167A1 Multiparticulate o-desmethylvenlafaxine salts and uses thereof
10/18/2006	EP1572683B1 Novel piperidine derivatives as modulators of chemokine receptor ccr5
10/18/2006	EP1358332B1 A serpin in bifidobacteria
10/18/2006	EP1272203B1 Treatment of neurodegenerative gastrointestinal disorders by implanting neural stem cells and/or progeny thereof into gastrointestinal organs
10/18/2006	EP1212070B1 Plant extract mixtures (cissus, vernonia, brillantaisia) and their uses
10/18/2006	EP1208196B1 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof
10/18/2006	EP1194554B1 Delivery of trefoil peptides
10/18/2006	EP1150577B1 Improved microbial preparations
10/18/2006	EP1042468B1 Low-voltage activated calcium channel compositions and methods
10/18/2006	EP0991661B1 Chimeric interleukin-6 soluble receptor/ligand protein, analogs thereof and uses thereof
10/18/2006	EP0656788B1 Hla binding peptides and their uses
10/18/2006	CN2827370Y 纤维素丸 Cellulose pill
10/18/2006	CN2827007Y 植物口香糖 Plant gum
10/18/2006	CN1849320A Process for the preparation of renzapride and intermediates thereof
10/18/2006	CN1849135A Methods for treating interleukin-6-related diseases
10/18/2006	CN1849118A Nonsedating alpha-2 agonist 1- (2, 3-dimethyl-phenyl) -ethyl-1, 3-dihydro-imizadole-2-thione
10/18/2006	CN1847261A Cyclic peptides as g-protein-coupled receptor antagonists
10/18/2006	CN1847252A Prepn process and medicinal composition of amorphous Adefovir dipivoxil
10/18/2006	CN1847240A Prazole derivative and its salt and use
10/18/2006	CN1847229A Novel compounds
10/18/2006	CN1846778A Sanzhi capsule
10/18/2006	CN1846764A Health medicinal wine
10/18/2006	CN1846759A Kidney invigorating and heart nourishing Hongfu ointment
10/18/2006	CN1846752A Belladonna extract preparing process
10/18/2006	CN1846742A Chinese herbal medicine for treating gastropathy and its prepn process
10/18/2006	CN1846736A Intestine recovering groundcherry capsule and its prepn process
10/18/2006	CN1846726A Capillary artemisia dripping pill and its prepn process
10/18/2006	CN1846725A Application of licoflavone in preparing medicine for treating inflammatory enteropathy
10/18/2006	CN1846718A Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions
10/18/2006	CN1846706A Application ammonium glycyrrhizunate in preparing medicine for inflammatory enteropathy
10/18/2006	CN1846705A Application of glycyrrhizic acid and glycyrrhetic acid in preparing medicine for inflammatory enteropathy
10/18/2006	CN1846696A Method for producing enantiomer-free n-methyl-n- [(1s)-1-phenyl- 2-((3s)- 3-hydroxypyrrolidine- 1-yl)ethyl]- 2,2-diphenyl acetamide
10/18/2006	CN1846518A Plum food producing process
10/18/2006	CN1280409C Health protecting product composition with liver protecting and blood fat regulating function and its preparation
10/18/2006	CN1280304C Fern effective part and compound fern glycoside and its separaton and purification method
10/18/2006	CN1280287C Process for producing crystal
10/18/2006	CN1279975C Inducer of blood vessel neogenesis
10/18/2006	CN1279974C Technology for preparing capsule of liver cell growth promoting factor
10/18/2006	CN1279945C Chinese herbal medicine prepn for reversing liver cirrhosis
10/18/2006	CN1279927C Traditional Chinese medicinal compocition for treating pancreatitis, cholecystitis, appendicitis and acute and chronic gastro enteritis
10/18/2006	CN1279925C Capsules of complete active substances of pilose antler and their preparation
10/18/2006	CN1279924C Application of bioactive glass in preparing medicine for treating gastroduodenal ulcer
10/18/2006	CN1279920C Slow release preparation of diammonium glycyrrhizate

1 ... 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 ... 1258